• Explore /
  • Poster
  • / Gastric cancer (GC) cohort of a phase 2 trial of E7389-LF (liposomal formulation of eribulin) in combination with nivolumab.

Gastric cancer (GC) cohort of a phase 2 trial of E7389-LF (liposomal formulation of eribulin) in combination with nivolumab.

Abstract Poster

Authors

Kei Muro

Kei Muro

Aichi Cancer Center Hospital, Nagoya, Japan;

Kei Muro , Satoru Iwasa , Naotoshi Sugimoto , Hisato Kawakami , Takashi Oshima , Kensei Yamaguchi , Kaori Hino , Motohiro Hirao , Yukinori Kurokawa , Takeshi Kawakami , Naoki Takegawa , Hiroki Hara , Naoki Sumiyoshi , Daiko Matsuoka , Yohei Otake , Keisuke Yasuda , Takao Takase , Shuya Takashima , Taro Semba , Akihito Kawazoe

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04078295

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 339)

DOI

10.1200/JCO.2023.41.4_suppl.339

Abstract #

339

Poster Bd #

D20

Abstract Disclosures

Similar Posters

First Author: Kohei Shitara

First Author: Ilya Tsimafeyeu

First Author: Manish R. Patel

First Author: Marwan Fakih